The COVID-19 recommendations hydroxychloroquine, ivermectin, and now artemisinin all have one thing in common: They are antimalarial drugs or have such properties.
From the outset, malaria and COVID-19 are very distinct diseases.
The angiotensin-converting enzyme 2 receptor is involved in both malaria and COVID-19 infections.
Early in the pandemic, many studies recommended antimalarial and anti-parasitic drugs such as hydroxychloroquine, chloroquine, ivermectin, and artemisinin as potential treatment options for COVID-19.
These recommendations soon received backlash, with one reason being that malaria and COVID-19 seem to be very different diseases.
Professor Jose Luis Abreu, whose specialty is in plant science at The State University of Nuevo León, used the proposition of "Parallelism between malaria and COVID-19" as an explanation for why antimalarial drugs such as ivermectin, artemisinin, and hydroxychloroquine may be applied to COVID-19 in his protocol.
These drugs can also bind to COVID-19 spike proteins directly to prevent viral attachment to cell receptors and also prevent viral proliferation by blocking proteins that take part in viral replication.
No comments:
Post a Comment